Banking On Vaccine For EV71
from The Breakfast Grille Hosted by BFM Media
Peter Wulff, co-founder of Sentinext Theraputics, tells why the biotechnology company is banking on developing the vaccine for EV71, a virus that has been spreading in Asia. While incidences of deaths may be relatively low, survivors may suffer neural damage. The company needs to raise about $1 billion to bring the drug to the market. Currently it's funded by funds from the Malaysian government.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The Breakfast Grille?
This episode is 22 minutes long.
When was this The Breakfast Grille episode published?
This episode was published on September 13, 2010.
Can I download this The Breakfast Grille episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.